Green Cross Medical Science Corporation (KQ:142280) — Market Cap & Net Worth
Market Cap & Net Worth: Green Cross Medical Science Corporation (142280)
Green Cross Medical Science Corporation (KQ:142280) has a market capitalization of $56.95 Million (₩84.03 Billion) as of May 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #21389 globally and #1366 in its home market, demonstrating a -1.02% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Green Cross Medical Science Corporation's stock price ₩3865.00 by its total outstanding shares 21741926 (21.74 Million). Analyse cash flow conversion of Green Cross Medical Science Corporation to see how efficiently the company converts income to cash.
Green Cross Medical Science Corporation Market Cap History: 2015 to 2026
Green Cross Medical Science Corporation's market capitalization history from 2015 to 2026. Data shows change from $173.24 Million to $56.95 Million (-10.67% CAGR).
Index Memberships
Green Cross Medical Science Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$299.07 Billion | 0.02% | #659 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$299.07 Billion | 0.02% | #659 of 1384 |
Weight: Green Cross Medical Science Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Green Cross Medical Science Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Green Cross Medical Science Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Green Cross Medical Science Corporation's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.02x
Green Cross Medical Science Corporation's market cap is 0.02 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $132.66 Million | $86.16 Billion | -$1.89 Billion | 0.00x | N/A |
| 2017 | $143.56 Million | $98.39 Billion | -$1.35 Billion | 0.00x | N/A |
| 2018 | $150.22 Million | $86.32 Billion | -$10.71 Billion | 0.00x | N/A |
| 2019 | $77.35 Million | $94.09 Billion | -$16.20 Billion | 0.00x | N/A |
| 2020 | $231.33 Million | $113.38 Billion | $6.72 Billion | 0.00x | 0.03x |
| 2021 | $106.53 Million | $101.67 Billion | -$21.20 Billion | 0.00x | N/A |
| 2022 | $85.16 Million | $113.11 Billion | -$3.58 Billion | 0.00x | N/A |
| 2023 | $70.28 Million | $94.01 Billion | $1.80 Billion | 0.00x | 0.04x |
| 2024 | $52.75 Million | $103.85 Billion | $3.58 Billion | 0.00x | 0.01x |
| 2025 | $59.01 Million | $108.41 Billion | $3.67 Billion | 0.00x | 0.02x |
Competitor Companies of 142280 by Market Capitalization
Companies near Green Cross Medical Science Corporation in the global market cap rankings as of May 4, 2026.
Key companies related to Green Cross Medical Science Corporation by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.09 |
Green Cross Medical Science Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, Green Cross Medical Science Corporation's market cap moved from $173.24 Million to $ 56.95 Million, with a yearly change of -10.67%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩56.95 Million | -3.50% |
| 2025 | ₩59.01 Million | +11.87% |
| 2024 | ₩52.75 Million | -24.95% |
| 2023 | ₩70.28 Million | -17.47% |
| 2022 | ₩85.16 Million | -20.06% |
| 2021 | ₩106.53 Million | -53.95% |
| 2020 | ₩231.33 Million | +199.05% |
| 2019 | ₩77.35 Million | -48.51% |
| 2018 | ₩150.22 Million | +4.64% |
| 2017 | ₩143.56 Million | +8.22% |
| 2016 | ₩132.66 Million | -23.43% |
| 2015 | ₩173.24 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Green Cross Medical Science Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $56.95 Million USD |
| MoneyControl | $56.95 Million USD |
| MarketWatch | $56.95 Million USD |
| marketcap.company | $56.95 Million USD |
| Reuters | $56.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Green Cross Medical Science Corporation
Green Cross Medical Science Corporation manufactures and sells diagnostic reagents and medical devices in South Korea and internationally. The company offers immunology diagnostic reagents. It also provides COVID-19 kit; blood glucose monitoring system; HbA1c test machine; and Gcare LIPID and LIPID printer. Green Cross Medical Science Corporation was founded in 1972 and is headquartered in Yongin… Read more